Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants

Triple-negative breast cancers (TNBCs), defined by lack of expression of estrogen receptor, progesterone receptor and HER2, account for 12–17% of breast cancers and are clinically perceived as a discrete breast cancer subgroup. Nonetheless, TNBC has been shown to constitute a vastly heterogeneous di...

Descripción completa

Detalles Bibliográficos
Autores principales: Pareja, Fresia, Geyer, Felipe C, Marchiò, Caterina, Burke, Kathleen A, Weigelt, Britta, Reis-Filho, Jorge S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515338/
https://www.ncbi.nlm.nih.gov/pubmed/28721389
http://dx.doi.org/10.1038/npjbcancer.2016.36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515338/
https://www.ncbi.nlm.nih.gov/pubmed/28721389
http://dx.doi.org/10.1038/npjbcancer.2016.36

Ejemplares similares